Schering Corporation and The Government of the United State of America, as represented by the

Patent application number	Title	Published
Schering Corporation and The Government of the United State of America, as represented by the Patent applications
20100111954	USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.	05-06-2010